Here, we provide in vitro and in vivo evidence that the HDAC inhibitor vorinostat sensitizes mesenchymal-like TNBC to AFP464, at least in part, through reactivation of ERα expression and restoration of AhR responsiveness to AF. This evidence concerns the gene ESR1 and atrial fibrillation.